116 related articles for article (PubMed ID: 23255042)
1. Question 2: Does intranasal sumatriptan use relieve migraine in children and young people?
Yong JW; Anand G
Arch Dis Child; 2013 Jan; 98(1):82-4. PubMed ID: 23255042
[No Abstract] [Full Text] [Related]
2. Intranasal sumatriptan for migraine in children.
Goldman RD; Meckler GD
Can Fam Physician; 2015 May; 61(5):435-7. PubMed ID: 25971759
[TBL] [Abstract][Full Text] [Related]
3. Breath-Powered Intranasal Sumatriptan Dry Powder.
Tepper D
Headache; 2016 Apr; 56(4):817-8. PubMed ID: 27092539
[No Abstract] [Full Text] [Related]
4. Onzetra Xsail--sumatriptan nasal powder.
Med Lett Drugs Ther; 2016 Jul; 58(1499):92-3. PubMed ID: 27403783
[No Abstract] [Full Text] [Related]
5. Sumatriptan iontophoretic patch for migraine.
Tepper DE
Headache; 2014 Oct; 54(9):1563-4. PubMed ID: 25324166
[No Abstract] [Full Text] [Related]
6. A sumatriptan patch (Zecuity) for migraine.
Med Lett Drugs Ther; 2015 Nov; 57(1481):151-2. PubMed ID: 26529132
[No Abstract] [Full Text] [Related]
7. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications for breath-powered powder sumatriptan intranasal treatment.
Tepper SJ
Headache; 2013 Sep; 53(8):1341-9. PubMed ID: 23809006
[TBL] [Abstract][Full Text] [Related]
9. Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headaches.
Freitag FG
Expert Rev Neurother; 2011 Apr; 11(4):481-90. PubMed ID: 21469920
[TBL] [Abstract][Full Text] [Related]
10. A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.
Silberstein SD
Expert Opin Drug Saf; 2018 Jan; 17(1):89-97. PubMed ID: 28994319
[TBL] [Abstract][Full Text] [Related]
11. Commentary.
Rothrock JF
Headache; 2011 Apr; 51(4):518-9. PubMed ID: 21457236
[No Abstract] [Full Text] [Related]
12. AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine.
Silberstein S
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):821-832. PubMed ID: 28605258
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
Blumenfeld A; Gennings C; Cady R
Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
[TBL] [Abstract][Full Text] [Related]
14. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
Meadows KP; Pierce M; O'Neill C; Foster S; Jennings C
Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
[TBL] [Abstract][Full Text] [Related]
15. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
Schulman EA
Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
[TBL] [Abstract][Full Text] [Related]
16. Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
Pierce M; O'Neill C; Felker E; Sebree T
Headache; 2013 Sep; 53 Suppl 2():34-42. PubMed ID: 24024601
[TBL] [Abstract][Full Text] [Related]
17. A review of needle-free sumatriptan injection for rapid control of migraine.
Rothrock JF; Freitag FG; Farr SJ; Smith EF
Headache; 2013 Sep; 53 Suppl 2():21-33. PubMed ID: 24024600
[TBL] [Abstract][Full Text] [Related]
18. Oral sumatriptan and almotriptan--delimiting the MAOI effect.
Oberhardt F; Fox AW
Headache; 2012 May; 52(5):765-72. PubMed ID: 22435741
[TBL] [Abstract][Full Text] [Related]
19. Emerging migraine treatments and drug targets.
Olesen J; Ashina M
Trends Pharmacol Sci; 2011 Jun; 32(6):352-9. PubMed ID: 21459461
[TBL] [Abstract][Full Text] [Related]
20. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
Rothrock JF; Cady RK; Aurora SK; Brandes JL; Myers JA; Fox AW; Farr SJ
Curr Med Res Opin; 2011 Nov; 27(11):2185-91. PubMed ID: 21942531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
